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Abstract
The aim of this pilot study is to obtain estimates for the change in maternal cerebrovascular (primary) and offspring vascular
structure (secondary) during healthy pregnancy that includes structured exercise. Eighteen pregnant women self-assigned to a
moderate-intensity aerobic exercise intervention or a control group. Maternal cerebral blood flow (CBF) at the middle cerebral
artery, cerebro- and peripheral-vascular function was assessed at the end of each trimester. Offspring carotid artery intima-media
thickness (IMT) was measured within 12 weeks of birth. For exploratory purposes, we performed statistical analysis to provide
estimates of the change for primary and secondary outcome variables. Maternal CBF reduced (− 8 cm s−1 [− 14 to − 2]) with
evidence of change to cerebral autoregulation (normalised gain: 0.12 %cm s−1% mmHg−1mmHg/% [− 0.18 to 0.40]) during
pregnancy. Offspring carotid IMT was smaller in the exercise group (− 0.04 mm [− 0.12–0.03]) compared with controls. Based
upon this data, a sample size of 33 and 57 in each group is required for low-frequency normalised gain and offspring IMT,
respectively. This would provide 90% power to detect statistically significant (P < 0.05) between group differences in a
randomised controlled trial. CBF is reduced in pregnancy, possibly due to reduced vascular resistance and altered maternal
cerebral autoregulation. Maternal exercise had negligible effects on cerebrovascular adaptation to pregnancy, but we observed
lower offspring carotid artery wall thickness following maternal exercise. Our directional findings and sample size estimations
should be explored in a fully powered randomised control trial.
Clinical trial registration: The trial was registered on March 14th at https://register.clinicaltrials.gov (NCT03079258).
Participant enrolment began on 3rd April 2016.
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Introduction
Pregnancy is associated with significant cardiovascular
(CV) adaptations including increased cardiac output,
blood volume and vasodilation alongside decreased
mean arterial pressure [1]. Increased vasodilation is crit-
ical for adequate delivery of oxygen and nutrients to the
foetus and is achieved in part, via an increased produc-
tion of vasoactive substances such as nitric oxide (NO)
at the vascular endothelium [2]. Underlying undetected
endothelial injury may impede essential vascular adap-
tation during pregnancy and plausibly underpin the
pathophysiology of cerebrovascular [3] and peripheral
vascular pregnancy-related complications [4]. For exam-
ple, cerebrovascular risk is four-to-six times higher in
women with pregnancy-related hypertensive disorders
[5] and this is expected to rise due to maternal obesity
and older age in pregnancy [6]. Improving our under-
standing of pregnancy-related cerebrovascular adaptation
is therefore warranted.
Maternal cerebral blood flow (CBF) declines during
pregnancy due to reduced blood pressure (BP) and vascu-
lar resistance [7]. The regulation of CBF in response to
changes in carbon dioxide (CO2) and BP, termed cerebral
autoregulation (CA), appears altered over the course of a
single healthy pregnancy [1, 8]. The upper and lower
limits of CA are extended beyond the non-pregnant range
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(60–160 mmHg) in an animal model which is likely a
protective mechanism against risk of pregnancy-related
ischemic brain injury in response to changes in BP [8].
An understanding of the pregnancy-related changes in CA
at each trimester of healthy human pregnancy is required
to advance current knowledge of the cerebrovascular risk
that accompanies complicated pregnancies. Similarly, the
time course of several structural and functional conduit
artery vascular adaptations, including brachial artery
flow-mediated dilation (FMD) and artery size (diameter),
thickness (carotid intima media thickness (IMT)) and
stiffness, have not been collectively described longitudi-
nally in a single cohort of pregnant women [9–13].
Characterising the integrity of the systemic vasculature
during a healthy pregnancy would allow for future com-
parison of the pathophysiological changes that result in
gestational diabetes and pre-eclampsia onset, both of
which have long-term consequences for maternal
cerebro- and peripheral-vascular disease risk [2].
Exercise is a modifiable lifestyle behaviour known to
positively influence cerebro- [14] and peripheral vascular
function in healthy adults [15]. Similarly, evidence sug-
gests that exercise during pregnancy improves brachial
FMD during the third trimester [16]. Importantly, the
CV benefits of gestational exercise may also translate to
the offspring. Maternal exercise positively impacts prog-
eny heart rate [17] and femoral artery endothelial cell
function in swine offspring [18]. Maternal exercise has
also shown to induce long-term vascular programming
into adulthood [19]. These data suggest that exercise dur-
ing pregnancy may program vascular adaptations in off-
spring as well as the mother; however, this has yet to be
investigated in a human cohort. Therefore, the aims of this
pilot study are to obtain estimates for the change in ma-
ternal cerebrovascular (primary) and offspring vascular
function (secondary) during healthy pregnancy that in-
cludes structured exercise.
Materials and Methods
Participant Characteristics Twenty-one singleton pregnant
participants were recruited at local pre-natal clinics be-
tween February 2017 and May 2018 (Fig. 1). Women were
eligible if they were in the first trimester of pregnancy,
non-smokers for at least 6 months, had no history of CV
disease, gestaional diabetes mellitus (GDM) or pre-
eclampsia, were not on any form of medication, participat-
ed in structured exercise less than twice/week and had a
body mass index (BMI) < 35 kg m−2. The inclusion of
women undertaking less than two exercise sessions per
week prior to their pregnancy was used as an indicator of
habitual exercise because the intervention implemented
was in line with previously published guidelines by the
Royal College of Obstetrics and Gynaecology for previ-
ously inactive pregnant women [20]. Women were exclud-
ed from the study if they developed any complication such
as pre-eclampsia, gestational diabetes or had incidence of
intrauterine growth restriction. All participants provided
written consent before taking part in the experimental pro-
cedure. Offspring characteristics including sex, gestational
age at birth and birth weight, alongside delivery method
including vaginal, C-section, ventouse and forceps were
collected from midwives using patient notes. This research
study was ethically approved by the National Health
Service Liverpool Central Research Ethics Committee
(Reference: 17/NW/0056), adhered to the Declaration of
Helsinki and was registered as a clinical trial at
ClinicalTrials.gov NCT03079258.
Experimental Procedure Participants were required to visit
the temperature-controlled (20–22 °C) laboratory on three
occasions having abstained from exercise for 24 h and
alcohol for 12 h as well as any food/caffeine/stimulants
6 h prior to the experiment. Each visit was completed at
the same t ime of day wi th in -pa r t i c ipan t s and
corresponded closely with the end of trimester 1 (T1;
12–14 weeks), trimester 2 (T2; 24–26 weeks) and trimes-
ter 3 (T3; 36–38 weeks). Participants completed a battery
of CV and cerebrovascular assessments in the following
order: neurovascular coupling (NVC), IMT, FMD, pulse
wave velocity (PWV), cerebrovascular reactivity (CVR)
and CA. The Astrand submaximal cycling test was per-
formed to estimate cardiorespiratory fitness (estimated
VO2peak). This test was chosen due to associated low
level of exertion and to minimise any injury risk that
might compromise exercise participation during the study.
Following each visit, participants recorded 7 days of ob-
jective physical activity (PA) and sedentary behaviour
monitoring. At the initial visit (T1), participants chose to
take part in a partially supervised exercise (EX) interven-
tion or to participate as a control (CONT). Those in the
control group received conventional care that involved
routine clinical visits with no interaction with the research
team or the exercise group. Routine clinical advice given
to women by midwives at the hospital was to refrain from
starting exercise in pregnancy if previously inactive, and
as such, no women in the CONT group were routinely
exercising. Within 12 weeks of birth, offspring artery
structure was measured and hospital records were used
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to acquire offspring characteristics and delivery informa-
tion via the midwifery team.
Pre-natal Measurements
Cerebrovascular Measurements
MCA and PCA Insonation Participants lay in a semi-recumbent
position and were fitted with a 2-MHz pulsed transcranial
Doppler (TCD) ultrasound system (DWL, Compumedics,
Germany) comprising a headband which supports an ultra-
sound probe on each side of the head. Ultrasound gel was
applied to the temporal window (just above the zygomatic
arch) and to the probes allowing an optimal signal to be ob-
tained. On either side of the cerebral headband, the posterior
cerebral artery (PCA) and middle cerebral artery (MCA) were
insonated, respectively, as described elsewhere [21]. Care was
taken to stabilise the probes ensuring a stable angle of
insonation in line with best practice guidelines [22].
Additionally, participants were instrumented with a mouth-
piece, nose clip, a bacteriological filter and a three-way valve
to allow for PETCO2 monitoring. Simultaneously, arterial
blood pressure was monitored non-invasively using a
Finometer photoplethysmography (Finometer pro, Finapres
Medical Systems, Netherlands) which was carefully fitted on
either the right hand’s middle or index finger as per manufac-
turer’s recommendations. Real-time MCAv and BP were re-
corded online and displayed in LabChart Pro version 7
(ADInstruments, Australia). The weighted mean MCAv and
PCAv were calculated from the peak envelope of the velocity
trace (1/3 systolic + 2/3 diastolic), which accounts for the rel-
ative time spent in each phase of the cardiac cycle [23]. Data
were expressed as cerebrovascular conductance (CVC), which
was calculated as MCAv divided by mean arterial pressure
(1/3SBP + 2/3DBP).
Neurovascular Coupling A 120-s baseline was recorded with
participant’s eyes open, followed by 120 s of eyes closed to
act as a familiarization phase. Participants were then asked to
open and close their eyes in 30-s intervals for a period of 5 min
as prompted by the researcher. During ‘eyes open’, partici-
pants were instructed to fixate on a red dot in the centre of a
moving black and white checkered image. The video was
displayed on an iPad (Apple) and held ~ 7 cm away from their
eyes to reduce the effects of external light. The same side for
MCA and PCA were insonated for repeated measurements to
ensure consistency. The visual stimulation used provides a
Fig. 1 Schematic of the
experimental procedure used.
Participants were recruited within
12 weeks of pregnancy for
vascular assessments. Participants
chose to join an exercise
intervention or continue with
conventional care and made two
subsequent visits at the end of T2
and T3 for vascular




strong mechanistic model of neurovascular coupling by in-
creasing neural activation of the occipital lobe [24].
Data was anaylsed following recommended guidelines
using an automated software [24]. First analysis of NVC
was performed by visually inspecting recordings on
LabChart for noise in the signals and artefacts. Interpolation
was used to replace any short segments and any larger seg-
ments were excluded. Data were extracted fromLabChart on a
beat-to-beat basis (peak, minimum and meanMCAv& PCAv
along with BP, PETCO2 and HR). Only the 5 cycles of 30-s
eyes-open-eyes-closed were extracted for analysis. Data was
run through the MATLAB script where the software com-
bines all the cycles into one average contour for each physio-
logical recording of each eyes-open-eyes-closed cycle. Time
to peak response, absolute and percentage change in the PCAv
were used to quantify the NVC response.
Cerebrovascular Reactivity Bilateral MCAv was employed to
assess CVR to perturbations in PaCO2 using a hypercapnic
rebreathing protocol described elsewhere [25]. In brief, partic-
ipants were instrumented again with a mouthpiece, nose clip, a
bacteriological filter and a three-way valve to allow switching
of airflow between room air and a pre-filled Douglas bag
containing a hypercapnic gas mixture of 5% CO2, 21% O2
balanced with nitrogen. Breath-by-breath CO2 was sampled
using a calibrated gas analyzer (Ml206, ADInstruments) and
the pressure of end-tidal carbon dioxide (PETCO2) was re-
corded online (LabChart) and corrected for the daily baromet-
ric pressure. A 1-min baseline recording was followed by a
period of voluntary hyperventilation until a reduction in
PETCO2 to < 20 Torr. Once achieved, participants inhaled
the 5% CO2 mixture from the Douglas bag and instructed to
return their respiratory rate to normal for 3 min. Data was
exported from LabChart Pro (ADInstruments Australia) and
analysed as previously described [26]. CVRwas quantified by
linear regression (R2 value). RelativeMCAvwas calculated as
the difference between baseline and 5% CO2 MCAv divided
by baseline MCAv (([5% CO2 MCAv-baseline MCAv] /
baseline MCAv) × 100%). Simultaneously during the CVR
test, CCA diameter was acquired at least 2 cm below the point
of bifurcation using high-resolution ultrasound. Images were
acquired in accordance with methodological guidelines [27].
Data were used to determine the response of the CCA to
elevations in PETCO2 by averaging 30 s of baseline diameter
and comparing that to the diameter during the last 30 s of 5%
CO2 breathing.
Cerebrovascular Autoregulation Changes in BP and MCAv
were assessed using a squat to stand procedure in order to
induce transient changes in arterial BP. Participants performed
squat-stand maneuvers at 0.10 Hz (5 s squat and 5 s stand)
whilst breathing normal atmospheric air for a duration of
6 min with PETCO2 monitored throughout. MCAv,
PETCO2 and MAP were extracted from LabChart every
0.1 s across the 6-min period. The relationship between chang-
es in MCAv and arterial BP was assessed via the transfer
function analysis (TFA) in accordance with standardised
guidelines [28]. Transfer function analysis was performed
using MATLAB (MathWorks-Inc., Natick, MA) in order to
calculate associated power (gain) and timing (phases) over
three different frequencies; very low (0.02–0.07 Hz), low
(0.07–0.20 Hz) and high (0.20–0.50 Hz) [28]. TFA also pro-
duces an estimated reliability of the relationship between the
two signals (coherence) [29]. Data sets with a coherence value
of < 0.4 Hz were excluded from data analysis. High frequency
and very low frequency range data were excluded from anal-
ysis based on the frequency of the squat-stands used.
Vascular Structure and Function
Carotid and Femoral Intima-Media Thickness Following
20 min of rest in a semi-recumbent position, the left common
carotid artery (CCA) was imaged using high-resolution B-
mode ultrasound (Terason u-smart 3300, Teratech,
Burlington, MA, USA) from three angles (approximately
45°, 90° and 135°), 5 mm proximal to the artery bulb [30].
Images were optimised to ensure clear contrast between the
artery walls and lumen with a distinct IMT visualised on the
far wall defined as the distance between two echogenic lines
represented by the lumen-intima interface and media adventi-
tia interface of the artery wall. The IMT was also acquired at
the left femoral artery 3 to 5 cm distal to the bifurcation using
the same criteria as for CCA. Each image was recorded by the
same sonographer for 30–40 s.
Recordings were analysed offline using the edge detection
software Carotid Studio v4.3.1 (Cardiovascular Suite, Quipu
srl, Pisa, Italy) with a frame rate of 25 frames per second as
described elsewhere [31]. Continuous calculations by the soft-
ware produced an average IMT and artery diameter recorded
and was repeated for all three angles and an average of the
three angles was calculated. This method has been shown to
be valid and reproducible. The extracted data were also used
to calculate wall-to-lumen ratio (IMT/lumen) at each arterial
site which corrects for differences in baseline diameter.
Arterial Stiffness Carotid-femoral PWV was assessed using a
semi-automated device and software (SphygmoCor, AtCor
Medical, Sydney, Australia) in the semi-recumbent position
as previously reported in pregnant populations [32]. Firstly,
three brachial artery BP measurements were taken in succes-
sion (Dinamap V100, GE Medical Systems, Germany), with
an average systolic (SBP) and diastolic (DBP) calculated and
entered into the software. A single applanation tonometer
probe was used to capture a proximal (carotid artery) and
distal (femoral artery) pulse, recorded over 10 cardiac cycles.
The QRS complex was measured simultaneously using
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electrocardiography (ECG). The time between the R wave of
the ECG trace and the foot of the proximal waveform is
subtracted from the time between the R wave and the foot of
the distal waveform to obtain the pulse transit time. To deter-
mine the distance used for PWV, the distance from the prox-
imal measurement site to the suprasternal notch was
subtracted from the distance between the distal measurement
site and the suprasternal notch using callipers. PWV was au-
tomatically calculated by dividing the distance between the
two arterial recording sites by transit time to provide an index
of arterial stiffness. PWV measurements were made in tripli-
cate and an average was calculated and used in data analysis.
Brachial and Femoral Flow-Mediated Dilation Left brachial
and left femoral artery diameters were assessed simultaneous-
ly via high-resolution 2D duplex ultrasound (Terason u-smart
3300, Teratech) with a 10–12 MHz linear array probe. B-
mode images were obtained and optimised, and the probe
was held in the same position for the duration of the test.
After 1 min of baseline measurement, occlusion cuffs, con-
nected to a rapid inflator (Hokanson, Bellevue, WA), placed
around the left thigh, proximal to the patella, and the left
forearm, distal to the humeral epicondyle, were inflated to a
supra-systolic pressure of 220 mmHg for 5 min. Arterial im-
ages were recorded for a further 3-min post cuff deflation in
accordance with best practice guidelines [33].
Brachial FMD (bFMD) and femoral FMD (fFMD) data
were analysed as described elsewhere [34] using a validated
custom edge detection and wall tracking software (Dicom
Encoder) [35]. FMD data was analysed with covariate control
for baseline artery diameter (adjusted FMD) allowing FMD to
be scaled for changes in artery diameter [36].
Anthropometry and Body Composition Stature and bodymass
were recorded to the nearest 0.1 cm using a stadiometer and
digital scales, respectively. Body mass index (BMI) was cal-
culated as bodymass in kilograms divided by stature in metres
squared (kg m−2). Skinfold thickness measurements were per-
formed at the biceps, triceps and subscapular landmarks as
described elsewhere [37] and in line with the International
Standards for Anthropometric Assessment Manual to calcu-
late body fat percentage (BF%) [38].
Physical Activity Physical activity was monitored using a tri-
axial accelerometer (Actigraph wGT3x-BT). Participants
wore the accelerometer on their right hip for 7 consecutive
days at the end of T1, T2 and T3. Participants removed the
device for sleeping, contact sports and water-based activities
and recorded the times the device was worn on a diary sheet
provided. Non-wear time was defined as 90 consecutive mi-
nutes of zero counts min−1 [39]. Inclusion criteria for analysis
were ≥ 10 h of wear time per day, for a minimum of 4 days,
including one weekend day [40]. The Actilife software,
version 6.2 (ActiGraph, Pensacola, Florida), was used to
download the data. Raw acceleration data was converted to
60-s epoch activity count data (counts min−1). PA intensity
was determined using the following cut points: light (≤ 2689
counts min−1), moderate (≤ 6166 counts min-1) and vigorous
(> 6167 counts min−1) [41]. Activity data were exported and
handled in Excel (Microsoft) and total time (minutes) spent
daily in light, moderate and vigorous activity was calculated.
Sedentary Behaviour Sedentary time was objectively mea-
sured using an activPAL activity monitor (activPAL mi-
cro, PAL Technologies Ltd., Glasgow, UK) worn contin-
uously for 7 days on the middle anterior of the right thigh.
Monitors were enclosed in a rubber sleeve and attached
by the researcher to the skin using a waterproof transpar-
ent seal (Tegaderm Roll, 3M). The monitor quantified the
time spent sitting, lying, standing and walking per day. A
sedentary bout was defined as no activity registered for at
least 60 s [42]. The raw data was downloaded from the
monitor using the activPAL proprietary software (version
7.2, 32) from which data were exported to Excel
(Microsoft, UK). Seconds of sedentary time during wak-
ing hours were totalled and converted to minutes/day.
Cardiorespiratory Fitness Test Participants performed a sub-
maximal cycling test to estimate VO2peak as previously de-
scribed [43]. In brief, participants cycled at a self-selected
resistance and pace for 2-min to be familiarised to the cycle
ergometer. HR was monitored continuously throughout the
test using short-range telemetry (Polar H7, Kempele,
Finland) and noted at the end of each minute alongside RPE.
The test began with participants cycling with a load of 60 W
(W) for a period of 6 min. Participant’s VO2peak was estimated
using the Astrand-Rhyming nomogram based on mean HR
(corrected for age) in the final minute of the test and the me-
chanical load at that point. Estimated absolute and relative
VO2peak was calculated and reported.
Exercise Intervention
Participants began the exercise intervention after com-
pleting PA and sedentary behaviour monitoring in T1
(12–14 weeks) and continued until delivery at the end
of T3. The intervention commenced with 3 × 15-min con-
tinuous exercise sessions at the beginning of T2, 3 ×
30 min by the end of T2 and 4 × 30 in T3 in line with
previously published pregnancy exercise guidelines by
the Royal College of Obstetrics and Gynaecology
(RCOG) [20]. The authors acknowledge that these guide-
lines have been updated; however, this study had com-
menced prior to the release of the updated guidelines.
The intervention comprised aerobic exercise performed
on ergometer equipment at 60–70% estimated maximum
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heart rate (MHR). To account for pregnancy-related
changes to heart rate, the Borg rate of perceived exertion
scale [44] was also used. Participants were asked to ex-
ercise to a rating of 12–14 equating to some breathless-
ness although capacity to maintain a conversation in line
with guidelines at the time [20]. One session per week
was supervised by the researcher at the Liverpool John
Moores University gym and the remaining sessions were
completed at a Liverpool City Council gym for which
memberships were provided. Participants wore a Polar
Bluetooth Heart Rate Monitor (H10 Kempele, Finland)
during all sessions and HR was recorded via a personal
Polar Beat account which was remotely accessible to the
researcher. Compliance was verified by totalling the
number of sessions attended by each participant divided
by the minimum number of sessions achievable in that
time and is reported as a percentage. Adherence to the
exercise was checked by verifying the heart rate recorded
for each session by the Polar monitor. A session was
adhered to if HR was equal to or greater than 60% esti-
mated MHR.
Post-natal Measurements
Offspring Carotid Intima-Media Thickness Offspring carotid
IMT was measured within 12 weeks of delivery. The
common carotid artery was imaged using high-resolution
B-mode ultrasound (Terason u-smart 3300, Teratech,
Burlington, MA, USA) 5 mm proximal to the artery bulb
[30]. Offspring were held supine or semi-supine by a par-
ent with the neck slightly extended and where possible,
facing the contralateral side to allow for optimal longitu-
dinal imaging of the far-wall intima media interface at one
angle only due to the small neck space available to scan.
Images were recorded for 30–40 s and optimised to ensure
clear contrast between the artery walls and lumen with a
distinct IMT visualised on the far wall as described above.
All offspring underwent a carotid artery scan; however,
due to quality issues, one scan (EX group) was omitted
from the analysis.
From the cIMT recording, 6–8 s of clear IMT and artery
walls was selected for analysis using an edge detection soft-
ware (Motion JPEG Encoder V3, National Instruments, USA)
as described elsewhere [45]. This software allows frame by
frame viewing to ensure tracking of the artery wall and IMT
which was necessary given the movement from offspring dur-
ing scanning. Each frame was checked by the same sonogra-
pher, to ensure the diameter and IMT had been registered
correctly, and any tracking mistakes made by the software
were deleted. The extracted data were used to calculate IMT/
lumen to account for differences in baseline diameter. This
method is reliable and operator-independent, demonstrating
high levels of precision and accuracy for estimating conduit
artery diameter and wall thickness [46].
Statistical Analysis
Given that this is a pilot study to obtain estimates of primary
and secondary outcome variables, no a priori sample size was
calculated. The primary outcome in the study is low-
frequency normalised gain, a marker of dynamic cerebral
autoregulation and the primary comparison is between T2
and T3. These time points were chosen to capture a large
proportion of the vascular adaptation in pregnancy (T2) [47]
and secondly, because of the association between altered CA
in late pregnancy (T3) [48]. Using the data collected during
the study, we calculated post hoc power, and also the required
sample size for a future, fully powered randomised control
trial for both primary and secondary outcome variables
(G*Power 3.1.5).
For exploratory purposes, we performed statistical
analysis to provide an estimate of the changes in all out-
come variables (Statistical Package for Social Sciences).
Baseline (T1) participant characteristics were compared
using an independent t test. Cerebrovascular parameters,
FMD, IMT, cardiorespiratory fitness and PA were
analysed using linear mixed modelling. Significant inter-
actions and main effects were followed up using LSD
pairwise comparisons. An independent sample t test was
used to identify any differences between EX and CONT
group offspring IMT. Data are presented in the text as
mean [95% confidence interval] unless otherwise stated,
with exact p values. P values are presented but not
interpreted.
Results
Participant Characteristics On entry to the study, groups
were similar in age, BMI, BF, fitness and blood pressure
(Table 1). Of the 21 women enrolled in the study, 3 with-
drew (2 from the EX group) due to time commitment and
1 (CONT) laboured prior to the final measurement. None
of the participants developed any pregnancy-related com-
plications during this study. Body mass and BMI in-
creased by 10.7 kg [5, 17] and 4 kg m−2 [2, 6], respec-
tively, during pregnancy (Table 1) but similarly with each
intervention. There were negligible changes in SBP, DBP,
MAP and fitness change during pregnancy.
Exercise Intervention Overall compliance to the EX interven-
tion was 78% (T2, 84% and T3, 68%). The EX group engaged
in less sedentary time (456 min day−1 [411, 501] compared
with the CONT group (523 min day−1 [485, 562]; p = 0.03),
but there were no changes during pregnancy or with
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intervention. Light, moderate, vigorous and total PA or accel-
erometer wear time were similar during pregnancy across both
interventions (p > 0.05; Table 2).
Pre-Natal Measurements
Cerebrovascular Measurements Low-frequency normalised
gain changed by 0.12%cm s−1% mmHg−1mmHg/% [−
0.18, 0.40; main effect of time p = 0.08] during pregnan-
cy. Our data provided 65% power to detect a between-
group difference in low frequency normalised gain from
T2 to T3. Using this data, a sample size of 33 in each
group would provide 90% power to detect a statistically
significant (P < 0.05) between intervention differences in
low-frequency normalised gain in a future randomised
controlled trial. Low-frequency phase increased by 13.9°
[− 0.6, 28.5]; p = 0.06). These changes were similar for
the exercise intervention (Table 6).
Resting MCAv reduced during pregnancy (− 8 cm s−1 [−
14, − 2]; p = 0.02; Fig. 2) and this was similar with exercise.
PCAv during neurovascular coupling was higher in the EX
Table 2 Physical activity and sedentary behaviour for participants in the exercise and control group and the end of trimester 1, 2, and 3
Exercise group (N = 7) Control group (N = 11) Two-way ANOVA




464 ± 101 445 ± 85 458 ± 132 534 ± 110 553 ± 72 484 ± 103 0.70 0.03 0.49
Step count 5626 ± 1304 6051 ± 2315 6141 ± 1965 6072 ± 2254 5017 ± 1513 5136 ± 1822 0.89 0.33 0.45
Light PA (min day−1) 335 ± 79 346 ± 60 315 ± 97 322 ± 88 299 ± 76 301 ± 57 0.75 0.27 0.74
LPA % Wear time 39 ± 7 42 ± 5 38 ± 8 40 ± 12 36 ± 9 39 ± 8 - - -
Moderate PA
(min day−1)
29 ± 16 27 ± 19 30 ± 19 30 ± 9 25 ± 13 24 ± 24 0.71 0.78 0.81
MPA % Wear time 3 ± 2 3 ± 2 4 ± 2 4 ± 2 3 ± 2 3 ± 3 - - -
Vigorous (min day−1) 1 ± 2 1 ± 2 1 ± 2 1 ± 2 0 ± 1 1 ± 1 0.76 0.58 0.69
VPA % Wear time 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 - - -
Total PA (min day−1) 364 ± 92 373 ± 75 345 ± 106 355 ± 100 323 ± 83 326 ± 66 0.75 0.30 0.77
Avg. daily wear time
(min day−1)
847 ± 91 824 ± 78 814 ± 92 822 ± 89 848 ± 118 771 ± 76 0.30 0.59 0.59
Values are mean ± SD. Italics represent significant main effect (P < 0.05)
T1 trimester 1, T2 trimester 2, T3 trimester 3, PA physical activity, LPA light physical activity,MPAmoderate physical activity, VPA vigorous physical
activity, Avg average
Table 1 Descriptive characteristics of participants in the exercise and control group at the end of trimester 1, 2, and 3
Exercise group (N = 7) Control group (N = 11) Two-way ANOVA
Trimester T1 T2 T3 T1 T2 T3 Time Intervention Time ×
intervention
Age (years) 33 ± 4 33 ± 4 33 ± 2 33 ± 3 33 ± 3 34 ± 2 0.96 0.97 0.99
Body mass (kg) 62.0 ± 8.4 69.5 ± 8.6 73.3 ± 9.7 66.6 ± 7.7 73.0 ± 7.3 76.5 ± 6.6 0.01 0.24 0.99
BMI (kg m−2) 23 ± 3 26 ± 3 27 ± 4 24 ± 3. 26 ± 3 28 ± 3 0.01 0.87 0.96
Body fat (%) 22.3 ± 2.2 24.6 ± 3.7 25.4 ± 4.2 23.5 ± 3.7 25.1 ± 3.7 25.9 ± 4.2 0.11 0.95 0.97
SBP (mmHg) 99 ± 6 102 ± 7 104 ± 6 103 ± 12 105 ± 13 104 ± 7 0.68 0.36 0.69
DBP (mmHg) 60 ± 8 61 ± 6 66 ± 6 60 ± 6 60 ± 6 62 ± 7 0.17 0.38 0.64
Absolute V̇O2peak (L min
−1) 2.3 ± 0.6 2.5 ± 0.5 2.5 ± 0.4 2.5 ± 0.7 2.5 ± 0.7 2.5 ± 0.7 0.91 0.95 0.75
Estimated V̇O2peak (mL kg min
−1) 35.3 ± 10.2 34.0 ± 8.9 32.7 ± 7.5 36.7 ± 12.3 33.3 ± 11.4 30.9 ± 10.4 0.38 0.77 0.81
Values are mean ± SD. Italics represent significant main effect (p < 0.05)
T1 trimester 1, T2 trimester 2, T3 trimester 3, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, V̇O2 oxygen
consumption
Reprod. Sci.
group (43.7 cm s−1 [40.4, 47.0]) compared with the CONT
group (39.2 cm s−1 [36.5, 41.9]; p = 0.04). There were negli-
gible changes to cerebrovascular reactivity and associated pa-
rameters (basal PETCO2, linearity between MCAV and
PETCO2, absolute CVR, relative CVR or MAP response dur-
ing the CVR test) (Table 5).
Vascular Structure and Function Brachial artery resting
blood flow was higher in the EX group (1.60 ml s−1
[1 .03 , 2 .17 ] ) compared wi th the CONT group
(0.80 ml s−1 [0.34, 1.27]; main effect of intervention p =
0.04). Brachial artery resting blood flow was not influ-
enced by pregnancy (p = 0.66) and there was no time ×
intervention effect present (p = 0.76). Brachial artery diam-
eter increased during pregnancy (0.03 cm [0.01, 0.06]; p =
0.03) and this was similar with exercise. Brachial FMD,
allometrically scaled bFMD, TTP and SRAUC were un-
changed with pregnancy and exercise. Femoral artery
FMD decreased in pregnancy (3.5% [− 6.5, − 0.5]; p =
0.03; Fig. 3) and was similar with interventions. Femoral
artery resting blood flow, FMD, allometrically scaled
fFMD, femoral artery diameter, TTP or SRAUC were un-
changed with pregnancy and exercise (p > 0.05; Table 3).
Carotid artery diameter increased during pregnancy
(0.33 mm [0.07, 0.58]; p = 0.04) and was similar with in-
tervention. Carotid IMT did not change with pregnancy or
exercise (p > 0.05; Table 4). Carotid IMT/lumen decreased
during pregnancy (0.005 [− 0.01, 0.001]; p = 0.046) and
was similar with intervention. Femoral artery diameter,
fIMT and fIMT/lumen were unchanged with pregnancy
and exercise (p > 0.05). PWV reduced during pregnancy
(5.01 m s−1 [2.8, 7.2]; p = 0.09; Table 4). PWV was greater
in the EX group (5.3 m s−1 [1.6, 8.9]) compared with the
CONT group (4.7 m s−1 [3.0, 6.5]; main effect of interven-
tion p = 0.04). There was no time × intervention effect for
PWV (p = 0.68).
Post-natal Measurements
Gestational age born and birth weight were similar in the
EX and CONT group. No birth defects or adverse events
were reported during delivery. In the EX group, 3 babies
were born by normal delivery, 2 by C-section (elective), 1
by ventouse and 1 by rotational forceps delivery. In the
CONT group, 6 were born by normal delivery, 4 by C-
section (3 electives, 1 emergency) and 1 induced to nor-
mal delivery. This equated to 26% C-section in the EX
group and 36% in the CONT group.
Offspring carotid IMT was smaller the exercise group
compared with the control group (− 0.04 mm [− 0.12–
0.03]. Our data provided 31% power to detect a
between-intervention difference for offspring IMT. Using
this data, a sample size of 57 in each group would provide
90% power to detect a statistically significant (P < 0.05)
between-group difference in a randomised controlled trial.
Carotid IMT/lumen and lumen diameter were similar be-
tween interventions (Fig. 4).
Discussion
The aim of this pilot study was to obtain estimates for the
change in maternal cerebrovascular (primary) and offspring
vascular function (secondary) during healthy pregnancy that
included structured exercise. We provide preliminary
Fig. 2 Maternal middle cerebral artery velocity during pregnancy.MCAv
declined during pregnancy data for trimester 1, 2 and 3 which. *Main
effect for time; p < 0.05
Fig. 3 Femoral artery FMD during pregnancy. fFMD decreased
progressively during pregnancy. *Main effect of time; p < 0.05
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evidence that maternal cerebral autoregulation changes during
pregnancy. This observation is alongside a decline in MCAv
and reduced vascular resistance via increased carotid artery
diameter. These changes were not impacted by exercise dur-
ing pregnancy. We did observe evidence of lower offspring
carotid artery diameter following maternal exercise. Our di-
rectional findings and sample size estimations should be ex-
plored in a fully powered randomised control trial.
We provide the preliminary evidence of changes in dynam-
ic CA during each trimester of healthy human pregnancy.
Normalised gain represents the dampening effect of CA on
the magnitude of BP oscillations. Gain rises with increasing
BP frequencies and when increased, is indicative of dimin-
ished dynamic CA efficiency [49]. In the context of our find-
ings, this implies that BP oscillations increase during pregnan-
cy, resulting in a greater magnitude between BP and MCAv,
Table 4 Carotid and femoral artery structure and pulse wave velocity for exercise and control group at the end of trimester 1, 2 and 3
Exercise group (N = 7) Control group (N = 11) Two-way ANOVA
Trimester T1 T2 T3 T1 T2 T3 Time Intervention Time ×
intervention
Pulse wave velocity (m s−1) 5.36 ± 0.27 4.96 ± 0.71 5.51 ± 0.88 5.07 ± 0.57 4.49 ± 0.67 4.67 ± 1.29 0.09 0.04 0.68
Carotid artery
Lumen artery diameter (mm) 6.90 ± 0.43 7.08 ± 0.56 7.18 ± 0.33 6.78 ± 0.32 7.10 ± 0.49 7.14 ± 0.39 0.05 0.72 0.90
IMT (mm) 0.47 ± 0.06 0.49 ± 0.06 0.47 ± 0.05 0.51 ± 0.04 0.49 ± 0.04 0.49 ± 0.04 0.54 0.73 0.29
IMT/lumen 0.07 ± 0.01 0.07 ± 0.01 0.06 ± 0.00 0.08 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.046 0.19 0.21
Femoral artery
IMT (mm) 0.40 ± 0.06 0.41 ± 0.04 0.41 ± 0.09 0.37 ± 0.07 0.39 ± 0.07 0.40 ± 0.05 0.64 0.41 0.97
IMT/lumen 0.07 ± 0.01 0.08 ± 0.01 0.07 ± 0.02 0.07 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.96 0.55 0.84
Values are mean ± SD
IMT intima-media thickness
*p < 0.05 for time
Table 3 Brachial and femoral artery function for exercise and control group at the end of trimester 1, 2 and 3
Exercise group (N = 7) Control group (N = 11) Two-way ANOVA
Trimester T1 T2 T3 T1 T2 T3 Time Intervention Time × intervention
Brachial artery
Baseline flow (ml s−1) 1.6 ± 2.8 1.3 ± 1.3 1.9 ± 1.3 0.7 ± 0.8 0.8 ± 0.9 0.9 ± 0.9 0.66 0.04 0.76
Artery diameter (cm) 0.31 ± 0.04 0.32 ± 0.03 0.35 ± 0.04 0.30 ± 0.03 0.32 ± 0.04 0.32 ± 0.03 0.03 0.24 0.69
Peak artery diameter (cm) 0.33 ± 0.04 0.35 ± 0.03 0.39 ± 0.04 0.32 ± 0.03 0.35 ± 0.04 0.35 ± 0.04 0.02 0.16 0.29
Time to peak (s) 44 ± 11 37 ± 13 63 ± 21 66 ± 27 49 ± 23 49 ± 10 0.18 0.39 0.10
SRAUC (× 10
3) 17.2 ± 10.0 15.8 ± 8.2 23.0 ± 9.3 20.9 ± 6.8 19.3 ± 10.9 22.9 ± 6.0 0.17 0.33 0.74
FMD (%) 7.1 ± 3.4 7.6 ± 4.0 10.8 ± 5.0 8.1 ± 2.9 7.6 ± 2.3 6.8 ± 3.8 0.60 0.30 0.16
Adjusted FMD (%) 7.1 ± 2.1 7.5 ± 2.2 10.8 ± 2.4 7.9 ± 1.9 7.6 ± 1.8 6.6 ± 2.0 0.62 0.27 0.14
Femoral artery
Baseline flow (ml s−1) 0.9 ± 0.4 0.6 ± 0.3 0.7 ± 0.2 1.9 ± 2.1 0.8 ± 0.5 0.7 ± 0.6 0.23 0.14 0.40
Artery diameter (cm) 0.52 ± 0.04 0.54 ± 0.05 0.54 ± 0.05 0.51 ± 0.04 0.54 ± 0.05 0.54 ± 0.05 0.19 0.91 0.92
Peak artery diameter (cm) 0.58 ± 0.04 0.59 ± 0.05 0.57 ± 0.05 0.56 ± 0.04 0.57 ± 0.04 0.57 ± 0.06 0.72 0.51 0.83
Time to Peak (s) 64 ± 19 68 ± 44 105 ± 41 65 ± 34 55 ± 26 62 ± 27 0.15 0.06 0.17
SRAUC (× 10
3) 18.0 ± 5.0 13.7 ± 3.8 15.1 ± 5.3 23.3 ± 12.8 16.2 ± 7.2 16.5 ± 4.9 0.15 0.15 0.75
FMD (%) 10.8 ± 3.4 8.3 ± 2.9 6.6 ± 2.4 8.9 ± 3.3 6.3 ± 2.7 6.2 ± 5.9 0.03 0.19 0.84
Adjusted FMD (%) 11.2 ± 1.4 7.6 ± 1.5 6.5 ± 1.4 7.4 ± 1.8 6.1 ± 1.8 7.8 ± 1.8 0.02 0.18 0.88
Values are mean ± SD
SRAUC shear rate area under the curve, FMD flow mediated dilation
† p < 0.05 for condition
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such that CA efficiency is reduced. The second CA parameter,
phase, describes the synchronicity of oscillations of BP and
MCAv, and a greater phase indicates more efficient CA
whereby MCAv and BP waveforms are in sync with one
another [49]. In the context of our findings, this implies that
despite a greater magnitude between MCAv and BP, MCAv
response time is improved to maintain synchronised wave
forms and ensure intact CA during pregnancy. In the non-
pregnant state, the normal boundaries of CA lie between pres-
sures of ~ 60–150 mmHg [50]. Gestational animal models
have shown that pregnancy results in an extension of the upper
and lower limits of CA [8] and likely occurs to prepare and
protect the maternal brain against possible acute and drastic
fluctuations in blood pressure [50]. Our data broadly support
the animal data in that CA is altered during healthy pregnancy
and a larger study would provide sufficient estimates of the
upper and lower ranges in healthy pregnancy.
Like other studies, we have shown resting MCAv declines
[7]. The reason for MCAv reduction during pregnancy has
been attributed to reduced systolic blood pressure [51] and
Fig. 4 Offspring vascular outcomes data. Offspring cIMT (a) and IMT:lumen (c) are lower in offspring of exercising mothers compared with the control
group, while the lumen diameter is larger (b) in exercisers compared with the control group although not significant
Table 5 Maternal cerebral blood flow, neurovascular coupling and cerebrovascular reactivity data for participants in the exercise and control group at
the end of trimester 1, 2 and 3
Exercise group (N = 7) Control group (N = 11) Two-way ANOVA
Trimester T1 T2 T3 T1 T2 T3 Time Intervention Time ×
intervention
PCAv (cm s−1) 43.7 ± 9.1 45.5 ± 10.6 42.0 ± 5.3 43.5 ± 9.3 38.3 ± 4.9 35.8 ± 4.8 0.15 0.04 0.44
NVC response (%) 13 ± 6 14 ± 8 15 ± 9 14 ± 9 17 ± 8 18 ± 4 0.48 0.37 0.85
MCA CVC (cm s−1 mmHg−1) 0.92 ± 0.14 0.93 ± 0.28 0.87 ± 0.28 0.84 ± 0.13 0.87 ± 0.13 0.74 ± 0.11 0.46 0.07 0.84
MAP (mmHg) 84 ± 10 79 ± 18 83 ± 17 89 ± 11 84 ± 8 90 ± 12 0.42 0.16 0.96
PET CO2 (mmHg) 31.9 ± 1.8 33.8 ± 1.9 32.8 ± 1.5 33.0 ± 1.9 32.7 ± 2.1 32.8 ± 0.9 0.82 0.58 0.56
CO2 reactivity test
Carotid diameter (mm) 0.64 ± 0.01 0.66 ± 0.02 0.66 ± 0.01 0.64 ± 0.01 0.66 ± 0.02 0.67 ± 0.01 0.19 0.89 0.72
Carotid diameter (mm) (last
30 s)
0.66 ± 0.02 0.67 ± 0.02 0.67 ± 0.02 0.66 ± 0.01 0.67 ± 0.02 0.68 ± 0.01 0.51 0.74 0.96
Absolute CVR
(cm s−1 mmHg−1)
4.7 ± 1.4 4.4 ± 1.1 4.7 ± 1.5 4.3 ± 1.2 4.1 ± 1.0 3.6 ± 1.1 0.71 0.11 0.58
Relative CVR
(cm s−1 mmHg−1)
4.9 ± 1.4 4.9 ± 1.4 4.7 ± 1.4 4.3 ± 1.2 3.9 ± 0.9 4.3 ± 1.4 0.92 0.23 0.47
CVR (r2) 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.2 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.23 0.85 0.98
Values are mean ± SD. Italics represent significant main effect (P < 0.05)
T1 trimester 1, T2 trimester 2, T3 trimester 3, PCAv posterior cerebral artery velocity, NVC neurovascular coupling,MCA middle cerebral artery, CVC
cerebrovascular conductance, MAP mean arterial pressure, PETCO2 end-tidal carbon dioxide, CVR cerebrovascular reactivity
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downstream vasodilation of resistance vessels to help main-
tain a stable hemodynamic state [7, 52]. Although systolic
blood pressure was similar during each trimester, carotid ar-
tery diameter increased during pregnancy. As an extracranial
vessel, an increase in carotid artery diameter reflects reduced
vascular resistance and thus implicates blood flow velocity
providing further insight and support for pregnancy-related
reductions in MCAv. Although not measured in this study, it
is plausible that MCA diameter may have increased further to
carotid artery enlargement. This may further explain de-
creased MCAv, although this remains speculative (Tables 5,
6 and 7).
The brachial and femoral arteries exhibited heteroge-
neous responses to pregnancy. In line with previous find-
ings, brachial artery diameter increased [53] and femoral
artery diameter was unchanged. To date no previous study
has examined femoral artery adaptation to a healthy un-
complicated pregnancy. We did observe a decline in the
function of the femoral but not the brachial artery. This
may be explained by the effect of increased body mass on
the vascular beds. Previous authors have reported the fem-
oral artery to be strongly correlated with BMI in compar-
ison to the brachial artery [54]. While the new exercise
guidelines for pregnant women may be more effective in
improving vascular function in line with previous research
[16], our intervention was effective in increasing brachial
but not femoral artery blood flow in the exercise group.
This adaptation may be indicative of a conditioning effect
on the vasculature resulting from repeated exercise bouts
that influence shear stress on the vascular wall [55].
Nonetheless, this finding highlights the complexity and
heterogeneity of the vascular tree and we suggest simul-
taneous cerebrovascular and peripheral vascular assess-
ments be used in future randomised controlled trials.
We were also interested whether structured exercise im-
pacts cerebro and peripheral vascular responses during preg-
nancy. This was of interest due to the benefit of exercise on
reducing the incidence of pregnancy-related CV complica-
tions including gestational diabetes and pre-eclampsia [56].
The exercise group demonstrated positive changes in some
cerebrovascular markers, including autoregulation and
neurovascular coupling. Our directional data suggest the ex-
ercise group preserved fitness to a greater extent compared
with the CONT group.
A novel aspect of this study was the investigation of off-
spring artery wall thickness within 12 weeks of delivery. We
Table 7 Offspring characteristics
at birth and carotid artery
measurements post-partum
Exercise group (N = 7) Control group (N = 11) p value
Male gender 3 6 -
Gestational age at birth (weeks) 39.7 ± 1.1 39.3 ± 1.4 0.72
Weight (kg) 3.5 ± 0.5 3.5 ± 0.4 0.50
Week of IMT measurement PP 8 ± 3 6 ± 2 0.24
IMT (mm) 0.45 ± 0.06 0.49 ± 0.07 0.27
Lumen (mm) 2.92 ± 0.13 2.88 ± 0.40 0.81
IMT/lumen 0.15 ± 0.02 0.17 ± 0.04 0.19
Values are mean ± SD
Table 6 Maternal cerebral autoregulation data for participants in the exercise and control group at the end of trimester 1, 2 and 3
Exercise group (N = 7) Control group (N = 11) Two-way ANOVA
Trimester T1 T2 T3 T1 T2 T3 Time Intervention Time ×
intervention
MAP 99 ± 11 98 ± 10 98 ± 9 101 ± 8 98 ± 10 98 ± 9 0.67 0.81 0.96
PETCO2 32.0 ± 2.8 34.7 ± 1.5 34.6 ± 1.4 33.8 ± 2.0 35.0 ± 1.1 35.8 ± 0.8 0.85 0.68 0.66
Gain (cm s−1 mmHg−1) 1.2 ± 0.3 1.3 ± 0.3 1.0 ± 0.1 0.9 ± 0.3 1.1 ± 0.3 1.0 ± 0.3 0.13 0.04 0.34
Phase (degrees) 21.1 ± 10.6 39.6 ± 8.4 34.7 ± 9.1 32.9 ± 13.2 32.8 ± 12.9 47.1 ± 29.4 0.06 0.26 0.10
Normalised gain
(%cm s−1% mmHg−1mmHg/%)
1.6 ± 0.5 1.9 ± 0.5 1.6 ± 0.3 1.3 ± 0.4 1.8 ± 0.5 1.6 ± 0.4 0.08 0.22 0.71
Coherence 0.66 ± 0.07 0.58 ± 0.16 0.62 ± 0.10 0.54 ± 0.14 0.63 ± 0.09 0.61 ± 0.09 - - -
Values are mean ± SD. Italics represent significant main effect (P < 0.05)
T1 trimester 1, T2 trimester 2, T3 trimester 3
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have demonstrated that performing vascular structural assess-
ment at the carotid artery in human offspring is feasible. We
show a lower directional offspring IMT following maternal
exercise and provide estimates of sample size for a fully
powered randomised control trial. Previous animal models
have shown a programming effect in vascular function in off-
spring of exercising mothers [18, 57]. Porcine maternal aero-
bic exercise training, comprising treadmill running 5 days a
week at 60–85% MHR, improves offspring thoracic aorta en-
dothelial cell function measured in vitro at 48 h after birth
[18]. The authors used a high exercise dose and it is possible
that the new exercise guidelines for pregnant women may
provide a greater stimulus for in utero vascular adaptation.
Elsewhere, intrauterine growth restriction results in thicker
abdominal aortic IMT compared with controls implying the
neonatal environment to influence the development of the
vascular system [58] further eluding to vascular programming
in utero. Taken together, further research in human pregnancy
is warranted.
This pilot study has a number of noteworthy strengths in-
cluding the employment of recommended methodology
guidelines for assessment of CA where the dynamic CA reg-
ulatory system can be maximally activated [28], FMD [59]
and previously published exercise guidelines in pregnancy
[20]. This study has achieved the aim of obtaining estimates
for the change in maternal cerebrovascular (primary) and off-
spring vascular function (secondary) during healthy pregnan-
cy that includes structured exercise. This will likely benefit
future randomised controlled trials within this population
and help advance current knowledge regarding pregnancy-
related systemic vascular health. From the pilot study, we
have also gain insight for future randomised control trials.
Our recruitment rate of 0.7 participants per month from a
single site and intervention was via patient choice. We suggest
that future trials should aim to maximise recruitment through
the use of multi-centre recruitment sites and establishing clin-
ical connections.
Study Limitations
Firstly, this trial is limited by the recruitment of women
at the end of their first trimester of pregnancy meaning
we were unable to obtain a pre-pregnancy baseline.
Although logistically extremely challenging, future inter-
ventions may look to recruit women prior to pregnancy
in order to truly understand the impact of pregnancy of
systemic vascular function and structure. We failed to
observe any differences between groups for PA that
may be due to the following limitations/factors: the ex-
ercise guidelines employed within this study have been
updated in the UK since the commencement of this trial
[60] with current guidelines recommending 150 min of
moderate intensity PA each week. It is plausible that the
exercise stimulus used in this study was too low to
influence the CV and lifestyle outcomes assessed be-
tween the exercise and control group. Furthermore, it
is plausible that not all PA including stationary cycling
and water-based activities have been captured by our
objective assessment. Future studies would benefit from
using an exercise training diary in addition to objective
measures. Thirdly, our study is predisposed to recruit-
ment bias as it was likely to appeal to women interested
in health and exercise which may explain the similar
PA levels observed between groups. The aerobic capac-
ity test used in this study has not been validated in
pregnancy and may have overestimated VO2peak due to
pregnancy-related increases in heart rate.
In summary, our preliminary evidence suggests thatMCAv
declines during pregnancy due to reduced vascular resistance
and possibly, altered CA. Exercise during pregnancy has some
positive effect on maternal and offspring vascular health that
should be examined in a larger randomised control trial
utilising the estimates from this study to calculate sample size
required.
Acknowledgements The authors would like to express their gratitude to
Gillian Houghton at The Liverpool Women’s Hospital and Kim Sefia of
One to One Midwives for facilitating the undertaking of this study and
assisting with participant recruitment.
Data Availability The authors support data transparency.
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no conflict of
interest.
Ethics Approval All procedures performed were ethically approved.
Consent to Participate Informed consent was obtained from all individ-
ual participants included in the study.
Consent for Publication All involved consented to publication.
Code Availability N/A
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adap-
tation, distribution and reproduction in any medium or format, as long as
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons licence, and indicate if changes were
made. The images or other third party material in this article are included
in the article's Creative Commons licence, unless indicated otherwise in a
credit line to the material. If material is not included in the article's
Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain




1. Steinback CD, King EC, Davenport MH. Longitudinal cerebrovas-
cular reactivity during pregnancy: a case study. Appl Physiol Nutr
Metab. 2015;40(6):636–9. https://doi.org/10.1139/apnm-2014-
0526.
2. Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endo-
thelial dysfunction in preeclampsia. J Endocrinol. 2017;232(1):
R27–44. https://doi.org/10.1530/JOE-16-0340.
3. Treadwell SD, Thanvi B, Robinson TG. Stroke in pregnancy and
the puerperium. Postgr Med J. 2008;84(991):238–45. https://doi.
org/10.1136/pgmj.2007.066167.
4. Srivaratharajah K, Abramson BL. Women and peripheral arterial
disease: a review of sex differences in epidemiology, clinical man-
ifestations, and outcomes. Can J Cardiol. 2018;34(4):356–61.
https://doi.org/10.1016/j.cjca.2018.01.009.
5. Ban L, Sprigg N, Abdul Sultan A, et al. Incidence of first stroke in
pregnant and nonpregnant women of childbearing age: a
population-based cohort study From England. J Am Hear Assoc.
2017;6(4). https://doi.org/10.1161/JAHA.116.004601.
6. Liu S, Chan W-S, Ray JG, Kramer MS, Joseph KS, System CPS.
Stroke and cerebrovascular disease in pregnancy: incidence, tem-
poral trends, and risk factors. Stroke. 2019;50(1):13–20.
7. Belfort MA, Tooke-Miller C, Allen JC Jr, et al. Changes in flow
velocity, resistance indices, and cerebral perfusion pressure in the
maternal middle cerebral artery distribution during normal pregnan-
cy. Acta Obs Gynecol Scand. 2001;80(2):104–12.
8. Chapman AC, Cipolla MJ, Chan SL. Effect of pregnancy and nitric
oxide on the myogenic vasodilation of posterior cerebral arteries
and the lower limit of cerebral blood flow autoregulation. Reprod
Sc i . 2013 ;20(9 ) :1046–54 . h t tp s : / / do i . o rg /10 .1177 /
1933719112473661.
9. Dorup I, Skajaa K, Sorensen KE. Normal pregnancy is associated
with enhanced endothelium-dependent flow-mediated vasodilation.
Am J Phys. 1999;276(3 Pt 2):H821–5.
10. Faber-Swensson AP, O’Callaghan SP, Walters WA. Endothelial
cell function enhancement in a late normal human pregnancy.
Aust N Z J Obs Gynaecol. 2004;44(6):525–9. https://doi.org/10.
1111/j.1479-828X.2004.00302.x.
11. Karkkainen H, Saarelainen H, Valtonen P, et al. Carotid artery
elasticity decreases during pregnancy - the cardiovascular risk in
young Finns study. BMC Pregnancy Childbirth. 2014;14:98.
https://doi.org/10.1186/1471-2393-14-98.
12. Quinton AE, Cook CM, Peek MJ. A longitudinal study using ul-
trasound to assess flow-mediated dilatation in normal human preg-
nancy. Hypertens Pregnancy. 2007;26(3):273–81. https://doi.org/
10.1080/10641950701366841.
13. Torrado J, Zocalo Y, Farro I, et al. Normal pregnancy is associated
with changes in central hemodynamics and enhanced Recruitable,
but not resting, Endothelial Function. Int J Reprod Med.
2015;2015:250951–10. https://doi.org/10.1155/2015/250951.
14. Murrell CJ, Cotter JD, ThomasKN, Lucas SJ,WilliamsMJ, Ainslie
PN. Cerebral blood flow and cerebrovascular reactivity at rest and
during sub-maximal exercise: effect of age and 12-week exercise
training. Age. 2013;35(3):905–20. https://doi.org/10.1007/s11357-
012-9414-x.
15. Bouaziz W, Lang P-O, Schmitt E, Leprêtre PM, Lefebvre F,
Momas C, et al. Effects of a short-term interval aerobic training
program with recovery bouts on vascular function in sedentary
aged 70 or over: a randomized controlled trial. Arch Gerontol
Geriatr. 2019;82:217–25.
16. Ramirez-Velez R, Aguilar de Plata AC, Escudero MM, et al.
Influence of regular aerobic exercise on endothelium-dependent
vasodilation and cardiorespiratory fitness in pregnant women. J
Obs Gynaecol Res. 2011;37(11):1601–8. https://doi.org/10.1111/
j.1447-0756.2011.01582.x.
17. May LE, Glaros A, Yeh HW, Clapp JF, Gustafson KM. Aerobic
exercise during pregnancy influences fetal cardiac autonomic con-
trol of heart rate and heart rate variability. Early Hum Dev.
2010;86(4):213–7. https://doi.org/10.1016/j.earlhumdev.2010.03.
002.
18. Newcomer SC, Taheripour P, Bahls M, Sheldon RD, Foust KB,
Bidwell CA, et al. Impact of porcine maternal aerobic exercise
training during pregnancy on endothelial cell function of offspring
at birth. J Dev Orig Heal Dis. 2012;3(1):4–9. https://doi.org/10.
1017/S2040174411000687.
19. Bahls M, Sheldon RD, Taheripour P, Clifford KA, Foust KB,
Breslin ED, et al. Mother’s exercise during pregnancy programmes
vasomotor function in adult offspring. Exp Physiol. 2014;99(1):
205–19. https://doi.org/10.1113/expphysiol.2013.075978.
20. Bell B, Dooley MM. Exercise in pregnancy. Roy Coll Ob Gyn
Statement No. 2012;4:7.
21. Willie CK, Colino FL, Bailey DM, Tzeng YC, Binsted G, Jones
LW, et al. Utility of transcranial Doppler ultrasound for the integra-
tive assessment of cerebrovascular function. J Neurosci Methods.
2011;196(2):221–37. https://doi.org/10.1016/j.jneumeth.2011.01.
011.
22. Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity
and chemoreflex control of breathing: mechanisms of regulation,
measurement, and interpretation. Am J Physiol Regul Integr Comp
Physiol. 2009;296(5):R1473–95. https://doi.org/10.1152/ajpregu.
91008.2008.
23. SkowRJ, MacKay CM, TymkoMM, et al. Differential cerebrovas-
cular CO(2) reactivity in anterior and posterior cerebral circulations.
Respir Physiol Neurobiol. 2013;189(1):76–86. https://doi.org/10.
1016/j.resp.2013.05.036.
24. Phillips AA, Chan FH, Zheng MM, Krassioukov AV, Ainslie PN.
Neurovascular coupling in humans: physiology, methodological
advances and clinical implications. J Cereb Blood Flow Metab.
2016;36(4):647–64. https://doi.org/10.1177/0271678X15617954.
25. Claassen JA, Zhang R, Qi F, Witkowski S, Levine BD.
Transcranial Doppler estimation of cerebral blood flow and cere-
brovascular conductance during modified rebreathing. J Appl
Physiol. 2007;102(3):870–7.
26. Carter SE, Draijer R, Holder SM, Brown L, Thijssen DHJ, Hopkins
ND. Regular walking breaks prevent the decline in cerebral blood
flow associated with prolonged sitting. J Appl Physiol.
2018;125(3):790–8. https://doi.org/10.1152/japplphysiol.00310.
2018.
27. Thomas KN, Lewis NC, Hill BG, Ainslie PN. Technical recom-
mendations for the use of carotid duplex ultrasound for the assess-
ment of extracranial blood flow. Am J Physiol Regul Integr Comp
Physiol. 2015;309(7):R707–20. https://doi.org/10.1152/ajpregu.
00211.2015.
28. Claassen JA, Meel-van den Abeelen AS, Simpson DM, Panerai
RB. Transfer function analysis of dynamic cerebral autoregulation:
a white paper from the international cerebral autoregulation re-
search network. J Cereb Blood Flow Metab. 2016;36(4):665–80.
https://doi.org/10.1177/0271678X15626425.
29. Triedman JK, Saul JP. Blood pressure modulation by central ve-
nous pressure and respiration. Buffering effects of the heart rate
reflexes. Circulation. 1994;89(1):169–79.
30. Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA,
D’Agostino RB Sr. Carotid-wall intima–media thickness and car-
diovascular events. N Engl J Med. 2011;365(3):213–21.
31. Bianchini E, Bozec E, Gemignani V, Faita F, Giannarelli C,
Ghiadoni L, et al. Assessment of carotid stiffness and intima-
media thickness from ultrasound data: comparison between two
methods. J Ultrasound Med. 2010;29(8):1169–75.
Reprod. Sci.
32. Robb AO, Mills NL, Din JN, Smith IBJ, Paterson F, Newby DE,
et al. Influence of the menstrual cycle, pregnancy, and preeclampsia
on arterial stiffness. Hypertension. 2009;53(6):952–8. https://doi.
org/10.1161/HYPERTENSIONAHA.109.130898.
33. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow-
mediated dilation in humans: a methodological and physiological
guideline. Am J Physiol Heart Circ Physiol. 2011;300(1):H2–12.
https://doi.org/10.1152/ajpheart.00471.2010.
34. Black MA, Green DJ, Cable NT. Exercise prevents age-related
decline in nitric-oxide-mediated vasodilator function in cutaneous
microvessels. J Physiol. 2008;586(14):3511–24. https://doi.org/10.
1113/jphysiol.2008.153742.
35. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C,
Taylor RR, et al. Improved analysis of brachial artery ultrasound
using a novel edge-detection software system. J Appl Physiol.
2001;91(2):929–37.
36. AtkinsonG,BatterhamAM. The percentage flow-mediated dilation
index: a large-sample investigation of its appropriateness, potential
for bias and causal nexus in vascular medicine. Vasc Med.
2013;18(6):354–65.
37. Kannieappan LM, Deussen AR, Grivell RM, Yelland L, Dodd JM.
Development of a tool for obtaining maternal skinfold thickness
measurements and assessing inter-observer variability among preg-
nant women who are overweight and obese. BioMed Cent.
2013;13(42):1–6.
38. Hume P, Marfell-Jones M. The importance of accurate site location
for skinfold measurement. J Sports Sci. 2008;26(12):1333–40.
39. Choi L, Liu Z, Matthews CE, Buchowski MS. Validation of accel-
erometer wear and nonwear time classification algorithm. Med Sci
Sport Exerc. 2011;43(2):357–64. https://doi.org/10.1249/MSS.
0b013e3181ed61a3.
40. Trost SG, McIver KL, Pate RR. Conducting accelerometer-based
activity assessments in field-based research. Med Sci Sport Exerc.
2005;37(11 Suppl):S531–43.
41. Sasaki JE, John D, Freedson PS. Validation and comparison of
ActiGraph activity monitors. J Sci Med Sport. 2011;14(5):411–6.
https://doi.org/10.1016/j.jsams.2011.04.003.
42. Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J,
Zimmet PZ, et al. Objectively measured sedentary time, physical
activity, and metabolic risk: the Australian Diabetes, Obesity and
Lifestyle Study (AusDiab). Diabetes Care. 2008;31(2):369–71.
https://doi.org/10.2337/dc07-1795.
43. Astrand PO, Ryhming I. A nomogram for calculation of aerobic
capacity (physical fitness) from pulse rate during sub-maximal
work. J Appl Physiol. 1954;7(2):218–21. https://doi.org/10.1152/
jappl.1954.7.2.218.
44. Borg G. Ratings of perceived exertion and heart rates during short-
term cycle exercise and their use in a new cycling strength test. Int J
Sport Med. 1982;3(3):153–8. https://doi.org/10.1055/s-2008-
1026080.
45. Potter K, Green DJ, Reed CJ, Woodman RJ, Watts GF, McQuillan
BM, et al. Carotid intima-medial thickness measured on multiple
ultrasound frames: evaluation of a DICOM-based software system.
Cardiovasc Ultrasound. 2007;5:29. https://doi.org/10.1186/1476-
7120-5-29.
46. Thijssen DH, Scholten RR, van denMunckhof IC, Benda N, Green
DJ, Hopman MT. Acute change in vascular tone alters intima-
media thickness. Hypertension. 2011;58(2):240–6. https://doi.org/
10.1161/HYPERTENSIONAHA.111.173583.
47. Broere-Brown ZA, Schalekamp-Timmermans S, Hofman A,
Jaddoe VWV, Steegers EAP. Fetal sex dependency of maternal
vascular adaptation to pregnancy: a prospective population-based
cohort study. BJOG. 2016;123(7):1087–95.
48. Euser AG, Cipolla MJ. Cerebral blood flow autoregulation and
edema formation during pregnancy in anesthetized rats.
Hypertension. 2007;49(2):334–40. https://doi.org/10.1161/01.
HYP.0000255791.54655.29.
49. Brackley KJ, Ramsay MM, Broughton Pipkin F, Rubin PC. A
longitudinal study of maternal bloodflow in normal pregnancy
and the puerperium: analysis of Doppler waveforms using
Laplace transform techniques. Br J Obs Gynaecol. 1998;105(1):
68–77.
50. Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to
pregnancy and its role in the neurological complications of eclamp-
sia. J Appl Physiol. 2011;110(2):329–39. https://doi.org/10.1152/
japplphysiol.01159.2010.
51. Williams K, Wilson S. Maternal middle cerebral artery blood flow
velocity variation with gestational age. Obstet Gynecol.
1994;84(3):445–8.
52. Zeeman GG, HatabM, Twickler DM.Maternal cerebral blood flow
changes in pregnancy. Am J Obs Gynecol. 2003;189(4):968–72.
53. Sierra-Laguado J, Garcia RG, Lopez-Jaramillo P. Flow-mediated
dilatation of the brachial artery in pregnancy. Int J Gynaecol Obstet.
2006;93(1):60–1. https://doi.org/10.1016/j.ijgo.2006.01.015.
54. Thijssen DH, Rowley N, Padilla J, et al. Relationship between
upper and lower limb conduit artery vasodilator function in
humans. J Appl Physiol. 2011;111(1):244–50. https://doi.org/10.
1152/japplphysiol.00290.2011.
55. Birk GK, Dawson EA, Atkinson C, Haynes A, Cable NT, Thijssen
DHJ, et al. Brachial artery adaptation to lower limb exercise train-
ing: role of shear stress. J Appl Physiol. 2012;112(10):1653–8.
56. Garnaes KK, Nyrnes SA, Salvesen KA, Salvesen O, Morkved S,
Moholdt T. Effect of supervised exercise training during pregnancy
on neonatal and maternal outcomes among overweight and obese
women. Secondary analyses of the ETIP trial: A randomised con-
trolled trial. PLoS One. 2017;12(3):e0173937. https://doi.org/10.
1371/journal.pone.0173937.
57. Blaize AN, Breslin E, Donkin SS, Cabot R, Pearson KJ, Newcomer
SC. Maternal exercise does not significantly alter adult rat offspring
vascular function. Med Sci Sport Exerc. 2015;47(11):2340–6.
https://doi.org/10.1249/MSS.0000000000000665.
58. Skilton MR, Evans N, Griffiths KA, Harmer JA, Celermajer DS.
Aortic wall thickness in newborns with intrauterine growth restric-
tion. Lancet. 2005;365(9469):1484–6. https://doi.org/10.1016/
s0140-6736(05)66419-7.
59. Thijssen DHJ, Bruno RM, van Mil A, et al. Expert consensus and
evidence-based recommendations for the assessment of flow-
mediated dilation in humans. Eur Heart J. 2019;40(30):2534–47.
60. Chief Medical Officer (CMO). UK Chief Medical Officers’
Physical Activity Guidelines. 2019.
Publisher’s Note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Reprod. Sci.
